GSK (GSK) News Today $33.60 +0.17 (+0.51%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period GSK reports mixed findings from ovarian cancer phase III studyDecember 20 at 10:56 AM | lse.co.ukGlaxoSmithKline (GSK) Gets a Hold from Goldman SachsDecember 20 at 10:56 AM | markets.businessinsider.comGSK Reports Headline Results From FIRST-ENGOT-OV44 Phase III Trial - Quick FactsDecember 20 at 10:56 AM | markets.businessinsider.comGSK's cancer drug combo meets main goal in ovarian cancer trialDecember 20 at 10:56 AM | msn.comGSK's cancer drugs meet progression-free survival goal in late-stage trialDecember 20 at 2:35 AM | reuters.comGSK (NYSE:GSK) Rating Lowered to "Buy" at StockNews.comStockNews.com cut GSK from a "strong-buy" rating to a "buy" rating in a research report on Friday.December 20 at 2:24 AM | marketbeat.comDeutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)December 17, 2024 | markets.businessinsider.comGSK announces CHMP of the EMA recommended expanding approval of JemperliDecember 16, 2024 | markets.businessinsider.comGSK announces FDA granted BTD for JemperliDecember 16, 2024 | markets.businessinsider.comGSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing PermissionDecember 16, 2024 | msn.comWilmington Savings Fund Society FSB Invests $787,000 in GSK plc (NYSE:GSK)Wilmington Savings Fund Society FSB purchased a new position in shares of GSK plc (NYSE:GSK - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 19,248 shares of the pharmaceutical company's stock, valuedDecember 16, 2024 | marketbeat.comPublic Employees Retirement System of Ohio Makes New Investment in GSK plc (NYSE:GSK)Public Employees Retirement System of Ohio acquired a new stake in GSK plc (NYSE:GSK - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 89,164 shares of the pharmaceutical company's stock, valued at approximately $3,645,000.December 16, 2024 | marketbeat.comZacks Research Issues Pessimistic Estimate for GSK EarningsDecember 16, 2024 | americanbankingnews.comZacks Research Issues Negative Forecast for GSK EarningsGSK plc (NYSE:GSK - Free Report) - Equities researchers at Zacks Research dropped their Q1 2026 EPS estimates for GSK in a note issued to investors on Wednesday, December 11th. Zacks Research analyst E. Bagri now forecasts that the pharmaceutical company will post earnings per share of $1.12 forDecember 16, 2024 | marketbeat.comZacks Research Has Negative Forecast for GSK Q1 EarningsDecember 15, 2024 | americanbankingnews.comSynovus Financial Corp Sells 46,216 Shares of GSK plc (NYSE:GSK)Synovus Financial Corp lowered its position in shares of GSK plc (NYSE:GSK - Free Report) by 20.7% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 176,801 shares of the pharmaceutical company's stock after selling 46,216 shDecember 14, 2024 | marketbeat.comVirtu Financial LLC Lowers Stock Position in GSK plc (NYSE:GSK)Virtu Financial LLC decreased its holdings in GSK plc (NYSE:GSK - Free Report) by 43.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,542 shares of the pharmaceutical company's stock after selling 22,9December 14, 2024 | marketbeat.comZacks Research Issues Pessimistic Forecast for GSK EarningsGSK plc (NYSE:GSK - Free Report) - Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of GSK in a research note issued on Wednesday, December 11th. Zacks Research analyst E. Bagri now forecasts that the pharmaceutical company will earn $1.10 per share for the quDecember 13, 2024 | marketbeat.comGSK plc (NYSE:GSK) Receives Average Rating of "Moderate Buy" from BrokeragesGSK plc (NYSE:GSK - Get Free Report) has received an average rating of "Moderate Buy" from the ten brokerages that are currently covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating and three have given a strong buy rating to the company. The aveDecember 13, 2024 | marketbeat.comGSK Executives Acquire Shares Under Reward PlanDecember 12, 2024 | tipranks.comGSK (NYSE:GSK) Raised to Strong-Buy at StockNews.comDecember 12, 2024 | americanbankingnews.comGSK (NYSE:GSK) Stock Rating Upgraded by StockNews.comStockNews.com upgraded GSK from a "buy" rating to a "strong-buy" rating in a report on Thursday.December 12, 2024 | marketbeat.comTD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)December 11, 2024 | markets.businessinsider.comGSK plc (NYSE:GSK) Holdings Cut by Wellington Management Group LLPWellington Management Group LLP lowered its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 7.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,904,058 shares of the pharmaceutical company's stDecember 11, 2024 | marketbeat.comState Street Corp Reduces Holdings in GSK plc (NYSE:GSK)State Street Corp lowered its position in GSK plc (NYSE:GSK - Free Report) by 0.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 6,777,921 shares of the pharmaceutical company's stock after selling 24,359 shares during the quarter. State StreetDecember 11, 2024 | marketbeat.comFDA to review GSK’s Nucala for COPDDecember 10, 2024 | finance.yahoo.comRelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritisDecember 10, 2024 | globenewswire.comGroupama Asset Managment Acquires 145,799 Shares of GSK plc (NYSE:GSK)Groupama Asset Managment lifted its stake in GSK plc (NYSE:GSK - Free Report) by 11.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,413,089 shares of the pharmaceutical company's stock after buying an additiDecember 10, 2024 | marketbeat.comY Intercept Hong Kong Ltd Sells 15,977 Shares of GSK plc (NYSE:GSK)Y Intercept Hong Kong Ltd lessened its holdings in GSK plc (NYSE:GSK - Free Report) by 23.1% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 53,078 shares of the pharmaceutical company's stock after selling 15,977 shares duriDecember 10, 2024 | marketbeat.comRelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritisDecember 10, 2024 | globenewswire.comGSK drug cut death risk by 42% in multiple myeloma studyDecember 9, 2024 | seekingalpha.comGSK's belantamab mafodotin reduced death risk by 42% in studyDecember 9, 2024 | msn.comGSK Gets Positive Results in Blood-Cancer Drug TrialDecember 9, 2024 | msn.comGSK says blood cancer drug shows dramatic survival gains in key trialDecember 9, 2024 | proactiveinvestors.comGSK's drug combo shown to cut risk of death by 42% in type of blood cancerDecember 9, 2024 | reuters.comGSK's Nucala and Blenrep receive regulatory boost in US and ChinaDecember 9, 2024 | lse.co.ukGSK: FDA Accepts For Review Submission For New Indication Of Nucala In COPDDecember 9, 2024 | markets.businessinsider.comStifel Financial Corp Grows Holdings in GSK plc (NYSE:GSK)Stifel Financial Corp grew its stake in shares of GSK plc (NYSE:GSK - Free Report) by 9.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 604,973 shares of the pharmaceutical company's stock after purchasing an additional 53December 9, 2024 | marketbeat.comXTX Topco Ltd Buys 19,721 Shares of GSK plc (NYSE:GSK)XTX Topco Ltd boosted its stake in GSK plc (NYSE:GSK - Free Report) by 68.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,325 shares of the pharmaceutical company's stock after purchasing an additionaDecember 8, 2024 | marketbeat.comGoldman Sachs Keeps Their Hold Rating on GlaxoSmithKline (GSK)December 6, 2024 | markets.businessinsider.comTaika Capital LP Acquires New Stake in GSK plc (NYSE:GSK)Taika Capital LP acquired a new stake in GSK plc (NYSE:GSK - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 25,150 shares of the pharmaceutical company's stock, valued at appDecember 6, 2024 | marketbeat.comMuna-GSK alliance to fast-track Alzheimer’s disease treatmentsDecember 6, 2024 | finance.yahoo.comHolocene Advisors LP Sells 5,624,394 Shares of GSK plc (NYSE:GSK)Holocene Advisors LP lowered its position in GSK plc (NYSE:GSK - Free Report) by 98.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 65,301 shares of the pharmaceutical company's stock after selling 5,624,394 shares during the period. HoDecember 6, 2024 | marketbeat.comGSK, Zhifei revise, extend strategic vaccine collaboration in ChinaDecember 5, 2024 | markets.businessinsider.comGSK, China’s Zhifei Extend Shingles Shot Collaboration to 2034December 5, 2024 | msn.comGSK, Zhifei Revise And Extend Strategic Vaccine Collaboration In ChinaDecember 5, 2024 | markets.businessinsider.comMuna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer's DiseaseDecember 5, 2024 | finance.yahoo.comGSK taps a startup for shot at Alzheimer’s drugDecember 5, 2024 | finance.yahoo.comGSK to get less from Zhifei shingles vaccine deal; to collaborate on RSVDecember 5, 2024 | msn.comGSK expands deal with China's Zhifei to explore RSV vaccine collaborationDecember 5, 2024 | reuters.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼-0.050.61▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼1913▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today Takeda Pharmaceutical News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Moderna News Today Viatris News Today Summit Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
